Research and Markets: Metastatic Renal Cell Cancer Pipeline Insights 2015 ... - Business Wire (press release) PDF Print

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/s32np9/metastatic_renal) has announced the addition of the "Metastatic Renal Cell Cancer-Pipeline Insights" report to their offering.

Summary

Metastatic Renal Cell Cancer- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Metastatic Renal Cell Cancer. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Metastatic Renal Cell Cancer Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Metastatic Renal Cell Cancer- Pipeline Insights Report covers the Metastatic Renal Cell Cancer pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Metastatic Renal Cell Cancer related therapeutic assessments by molecule type, route of administration, monotherapy and combination products.

Scope

  • The report provides a Metastatic Renal Cell Cancer Landscape across the globe
  • The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information
  • Coverage of the Metastatic Renal Cell Cancer pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • Pipeline products coverage based on various stages of development from NDA filings to discovery.
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Key Topics Covered:

  • Metastatic Renal Cell Cancer Overview
  • Metastatic Renal Cell Cancer Pipeline Therapeutics
  • Metastatic Renal Cell Cancer Therapeutics under Development by Companies
  • Metastatic Renal Cell Cancer Late Stage Products (Filed and Phase III)
  • Comparative Analysis
  • Metastatic Renal Cell Cancer Mid Clinical Stage Products (Phase II)
  • Comparative Analysis
  • Metastatic Renal Cell Cancer Early Clinical Stage Products (Phase I and IND Filed)
  • Comparative Analysis
  • Metastatic Renal Cell Cancer Discovery and Pre-Clinical Stage Products
  • Comparative Analysis
  • Drug Candidate Profiles
  • Metastatic Renal Cell Cancer - Therapeutics Assessment
  • Assessment by Monotherapy Products
  • Assessment by Combination Products
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Metastatic Renal Cell Cancer - Discontinued Products
  • Metastatic Renal Cell Cancer - Dormant Products
  • Companies Involved in Therapeutics Development for Metastatic Renal Cell Cancer

For more information visit http://www.researchandmarkets.com/research/s32np9/metastatic_renal

...

 
Share |
Copyright © 2017 Global Dialysis. All Rights Reserved.